121 related articles for article (PubMed ID: 10608756)
1. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Chuachoowong R; Shaffer N; Siriwasin W; Chaisilwattana P; Young NL; Mock PA; Chearskul S; Waranawat N; Chaowanachan T; Karon J; Simonds RJ; Mastro TD
J Infect Dis; 2000 Jan; 181(1):99-106. PubMed ID: 10608756
[TBL] [Abstract][Full Text] [Related]
2. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand.
Chuachoowong R; Shaffer N; VanCott TC; Chaisilwattana P; Siriwasin W; Waranawat N; Vanprapar N; Young NL; Mastro TD; Lambert JS; Robb ML
J Infect Dis; 2000 Jun; 181(6):1957-63. PubMed ID: 10837175
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
[TBL] [Abstract][Full Text] [Related]
5. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
Tuomala RE; O'Driscoll PT; Bremer JW; Jennings C; Xu C; Read JS; Matzen E; Landay A; Zorrilla C; Blattner W; Charurat M; Anderson DJ;
J Infect Dis; 2003 Feb; 187(3):375-84. PubMed ID: 12552421
[TBL] [Abstract][Full Text] [Related]
6. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women.
Natividad-Villanueva GU; Santiago E; Manalastas RM; Brown HW; Ingersoll J; Caliendo AM; Mayer KH; Cu-Uvin S
Int J STD AIDS; 2003 Dec; 14(12):826-9. PubMed ID: 14678591
[TBL] [Abstract][Full Text] [Related]
8. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.
Shaffer N; Roongpisuthipong A; Siriwasin W; Chotpitayasunondh T; Chearskul S; Young NL; Parekh B; Mock PA; Bhadrakom C; Chinayon P; Kalish ML; Phillips SK; Granade TC; Subbarao S; Weniger BG; Mastro TD
J Infect Dis; 1999 Mar; 179(3):590-9. PubMed ID: 9952365
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
[TBL] [Abstract][Full Text] [Related]
10. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
[TBL] [Abstract][Full Text] [Related]
11. Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
Chaisilwattana P; Chokephaibulkit K; Chalermchockcharoenkit A; Vanprapar N; Sirimai K; Chearskul S; Sutthent R; Opartkiattikul N
Clin Infect Dis; 2002 Dec; 35(11):1405-13. PubMed ID: 12439805
[TBL] [Abstract][Full Text] [Related]
12. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
Chalermchockcharoenkit A; Culnane M; Chotpitayasunondh T; Vanprapa N; Leelawiwat W; Mock PA; Asavapiriyanont S; Teeraratkul A; McConnell MS; McNicholl JM; Tappero JW
Clin Infect Dis; 2009 Jul; 49(2):299-305. PubMed ID: 19522656
[TBL] [Abstract][Full Text] [Related]
14. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers.
Montano M; Russell M; Gilbert P; Thior I; Lockman S; Shapiro R; Chang SY; Lee TH; Essex M
J Infect Dis; 2003 Aug; 188(3):406-13. PubMed ID: 12870122
[TBL] [Abstract][Full Text] [Related]
15. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
16. Viral load and perinatal transmission.
Sax PE
AIDS Clin Care; 1999 Oct; 11(10):84. PubMed ID: 11366707
[TBL] [Abstract][Full Text] [Related]
17. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
Coombs RW; Wright DJ; Reichelderfer PS; Burns DN; Cohn J; Cu-Uvin S; Baron PA; Cohen MH; Landay AL; Lewis S; Kovacs A;
J Infect Dis; 2001 Nov; 184(9):1187-91. PubMed ID: 11598843
[TBL] [Abstract][Full Text] [Related]
18. Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission.
Manigart O; Crepin M; Leroy V; Meda N; Valea D; Janoff EN; Rouet F; Dequae-Merchadoux L; Dabis F; Rouzioux C; Van de Perre P;
J Infect Dis; 2004 Oct; 190(8):1422-8. PubMed ID: 15378434
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
[TBL] [Abstract][Full Text] [Related]
20. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
